This report aims to provide a comprehensive presentation of the global market for Prolotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prolotherapy. This report contains market size and forecasts of Prolotherapy in global, including the following market information:
Global Prolotherapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Prolotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Joint injection prolotherapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prolotherapy include Pfizer Inc., Baxter International, B. Braun, Johnson & Johnson, Arthex Inc., Terumo Corporation, Aurobindo Pharma, Shandong Qidu Pharmaceuticals and Amphastar Pharmaceuticals Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prolotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prolotherapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Prolotherapy Market Segment Percentages, by Type, 2022 (%)
Joint injection prolotherapy
Ligament prolotherapy
Tendon reconstruction prolotherapy
Global Prolotherapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Prolotherapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Care Centers
Orthopedic Centres
Speciality Clinics
Academic and Research Institutes
Global Prolotherapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Prolotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prolotherapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prolotherapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Baxter International
B. Braun
Johnson & Johnson
Arthex Inc.
Terumo Corporation
Aurobindo Pharma
Shandong Qidu Pharmaceuticals
Amphastar Pharmaceuticals Inc.
Sanctus drugs & Pharmaceuticals
Hospira Pharmaceutical Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prolotherapy, market overview.
Chapter 2: Global Prolotherapy market size in revenue.
Chapter 3: Detailed analysis of Prolotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prolotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prolotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prolotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prolotherapy Overall Market Size
2.1 Global Prolotherapy Market Size: 2022 VS 2032
2.2 Global Prolotherapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prolotherapy Players in Global Market
3.2 Top Global Prolotherapy Companies Ranked by Revenue
3.3 Global Prolotherapy Revenue by Companies
3.4 Top 3 and Top 5 Prolotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prolotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prolotherapy Players in Global Market
3.6.1 List of Global Tier 1 Prolotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Prolotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prolotherapy Market Size Markets, 2022 & 2032
4.1.2 Joint injection prolotherapy
4.1.3 Ligament prolotherapy
4.1.4 Tendon reconstruction prolotherapy
4.2 By Type - Global Prolotherapy Revenue & Forecasts
4.2.1 By Type - Global Prolotherapy Revenue, 2018-2023
4.2.2 By Type - Global Prolotherapy Revenue, 2024-2032
4.2.3 By Type - Global Prolotherapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prolotherapy Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Ambulatory Care Centers
5.1.4 Orthopedic Centres
5.1.5 Speciality Clinics
5.1.6 Academic and Research Institutes
5.2 By Application - Global Prolotherapy Revenue & Forecasts
5.2.1 By Application - Global Prolotherapy Revenue, 2018-2023
5.2.2 By Application - Global Prolotherapy Revenue, 2024-2032
5.2.3 By Application - Global Prolotherapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Prolotherapy Market Size, 2022 & 2032
6.2 By Region - Global Prolotherapy Revenue & Forecasts
6.2.1 By Region - Global Prolotherapy Revenue, 2018-2023
6.2.2 By Region - Global Prolotherapy Revenue, 2024-2032
6.2.3 By Region - Global Prolotherapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Prolotherapy Revenue, 2018-2032
6.3.2 US Prolotherapy Market Size, 2018-2032
6.3.3 Canada Prolotherapy Market Size, 2018-2032
6.3.4 Mexico Prolotherapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Prolotherapy Revenue, 2018-2032
6.4.2 Germany Prolotherapy Market Size, 2018-2032
6.4.3 France Prolotherapy Market Size, 2018-2032
6.4.4 U.K. Prolotherapy Market Size, 2018-2032
6.4.5 Italy Prolotherapy Market Size, 2018-2032
6.4.6 Russia Prolotherapy Market Size, 2018-2032
6.4.7 Nordic Countries Prolotherapy Market Size, 2018-2032
6.4.8 Benelux Prolotherapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Prolotherapy Revenue, 2018-2032
6.5.2 China Prolotherapy Market Size, 2018-2032
6.5.3 Japan Prolotherapy Market Size, 2018-2032
6.5.4 South Korea Prolotherapy Market Size, 2018-2032
6.5.5 Southeast Asia Prolotherapy Market Size, 2018-2032
6.5.6 India Prolotherapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Prolotherapy Revenue, 2018-2032
6.6.2 Brazil Prolotherapy Market Size, 2018-2032
6.6.3 Argentina Prolotherapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prolotherapy Revenue, 2018-2032
6.7.2 Turkey Prolotherapy Market Size, 2018-2032
6.7.3 Israel Prolotherapy Market Size, 2018-2032
6.7.4 Saudi Arabia Prolotherapy Market Size, 2018-2032
6.7.5 UAE Prolotherapy Market Size, 2018-2032
7 Prolotherapy Companies Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Prolotherapy Major Product Offerings
7.1.4 Pfizer Inc. Prolotherapy Revenue in Global Market (2018-2023)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 Baxter International
7.2.1 Baxter International Company Summary
7.2.2 Baxter International Business Overview
7.2.3 Baxter International Prolotherapy Major Product Offerings
7.2.4 Baxter International Prolotherapy Revenue in Global Market (2018-2023)
7.2.5 Baxter International Key News & Latest Developments
7.3 B. Braun
7.3.1 B. Braun Company Summary
7.3.2 B. Braun Business Overview
7.3.3 B. Braun Prolotherapy Major Product Offerings
7.3.4 B. Braun Prolotherapy Revenue in Global Market (2018-2023)
7.3.5 B. Braun Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Prolotherapy Major Product Offerings
7.4.4 Johnson & Johnson Prolotherapy Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Arthex Inc.
7.5.1 Arthex Inc. Company Summary
7.5.2 Arthex Inc. Business Overview
7.5.3 Arthex Inc. Prolotherapy Major Product Offerings
7.5.4 Arthex Inc. Prolotherapy Revenue in Global Market (2018-2023)
7.5.5 Arthex Inc. Key News & Latest Developments
7.6 Terumo Corporation
7.6.1 Terumo Corporation Company Summary
7.6.2 Terumo Corporation Business Overview
7.6.3 Terumo Corporation Prolotherapy Major Product Offerings
7.6.4 Terumo Corporation Prolotherapy Revenue in Global Market (2018-2023)
7.6.5 Terumo Corporation Key News & Latest Developments
7.7 Aurobindo Pharma
7.7.1 Aurobindo Pharma Company Summary
7.7.2 Aurobindo Pharma Business Overview
7.7.3 Aurobindo Pharma Prolotherapy Major Product Offerings
7.7.4 Aurobindo Pharma Prolotherapy Revenue in Global Market (2018-2023)
7.7.5 Aurobindo Pharma Key News & Latest Developments
7.8 Shandong Qidu Pharmaceuticals
7.8.1 Shandong Qidu Pharmaceuticals Company Summary
7.8.2 Shandong Qidu Pharmaceuticals Business Overview
7.8.3 Shandong Qidu Pharmaceuticals Prolotherapy Major Product Offerings
7.8.4 Shandong Qidu Pharmaceuticals Prolotherapy Revenue in Global Market (2018-2023)
7.8.5 Shandong Qidu Pharmaceuticals Key News & Latest Developments
7.9 Amphastar Pharmaceuticals Inc.
7.9.1 Amphastar Pharmaceuticals Inc. Company Summary
7.9.2 Amphastar Pharmaceuticals Inc. Business Overview
7.9.3 Amphastar Pharmaceuticals Inc. Prolotherapy Major Product Offerings
7.9.4 Amphastar Pharmaceuticals Inc. Prolotherapy Revenue in Global Market (2018-2023)
7.9.5 Amphastar Pharmaceuticals Inc. Key News & Latest Developments
7.10 Sanctus drugs & Pharmaceuticals
7.10.1 Sanctus drugs & Pharmaceuticals Company Summary
7.10.2 Sanctus drugs & Pharmaceuticals Business Overview
7.10.3 Sanctus drugs & Pharmaceuticals Prolotherapy Major Product Offerings
7.10.4 Sanctus drugs & Pharmaceuticals Prolotherapy Revenue in Global Market (2018-2023)
7.10.5 Sanctus drugs & Pharmaceuticals Key News & Latest Developments
7.11 Hospira Pharmaceutical Company
7.11.1 Hospira Pharmaceutical Company Company Summary
7.11.2 Hospira Pharmaceutical Company Business Overview
7.11.3 Hospira Pharmaceutical Company Prolotherapy Major Product Offerings
7.11.4 Hospira Pharmaceutical Company Prolotherapy Revenue in Global Market (2018-2023)
7.11.5 Hospira Pharmaceutical Company Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prolotherapy Market Opportunities & Trends in Global Market
Table 2. Prolotherapy Market Drivers in Global Market
Table 3. Prolotherapy Market Restraints in Global Market
Table 4. Key Players of Prolotherapy in Global Market
Table 5. Top Prolotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prolotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prolotherapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prolotherapy Product Type
Table 9. List of Global Tier 1 Prolotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prolotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prolotherapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Prolotherapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prolotherapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Prolotherapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Prolotherapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prolotherapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Prolotherapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Prolotherapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prolotherapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Prolotherapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prolotherapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Prolotherapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prolotherapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Prolotherapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prolotherapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Prolotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prolotherapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Prolotherapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prolotherapy Revenue, (US$, Mn), 2024-2032
Table 30. Pfizer Inc. Company Summary
Table 31. Pfizer Inc. Prolotherapy Product Offerings
Table 32. Pfizer Inc. Prolotherapy Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Inc. Key News & Latest Developments
Table 34. Baxter International Company Summary
Table 35. Baxter International Prolotherapy Product Offerings
Table 36. Baxter International Prolotherapy Revenue (US$, Mn) & (2018-2023)
Table 37. Baxter International Key News & Latest Developments
Table 38. B. Braun Company Summary
Table 39. B. Braun Prolotherapy Product Offerings
Table 40. B. Braun Prolotherapy Revenue (US$, Mn) & (2018-2023)
Table 41. B. Braun Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Prolotherapy Product Offerings
Table 44. Johnson & Johnson Prolotherapy Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Arthex Inc. Company Summary
Table 47. Arthex Inc. Prolotherapy Product Offerings
Table 48. Arthex Inc. Prolotherapy Revenue (US$, Mn) & (2018-2023)
Table 49. Arthex Inc. Key News & Latest Developments
Table 50. Terumo Corporation Company Summary
Table 51. Terumo Corporation Prolotherapy Product Offerings
Table 52. Terumo Corporation Prolotherapy Revenue (US$, Mn) & (2018-2023)
Table 53. Terumo Corporation Key News & Latest Developments
Table 54. Aurobindo Pharma Company Summary
Table 55. Aurobindo Pharma Prolotherapy Product Offerings
Table 56. Aurobindo Pharma Prolotherapy Revenue (US$, Mn) & (2018-2023)
Table 57. Aurobindo Pharma Key News & Latest Developments
Table 58. Shandong Qidu Pharmaceuticals Company Summary
Table 59. Shandong Qidu Pharmaceuticals Prolotherapy Product Offerings
Table 60. Shandong Qidu Pharmaceuticals Prolotherapy Revenue (US$, Mn) & (2018-2023)
Table 61. Shandong Qidu Pharmaceuticals Key News & Latest Developments
Table 62. Amphastar Pharmaceuticals Inc. Company Summary
Table 63. Amphastar Pharmaceuticals Inc. Prolotherapy Product Offerings
Table 64. Amphastar Pharmaceuticals Inc. Prolotherapy Revenue (US$, Mn) & (2018-2023)
Table 65. Amphastar Pharmaceuticals Inc. Key News & Latest Developments
Table 66. Sanctus drugs & Pharmaceuticals Company Summary
Table 67. Sanctus drugs & Pharmaceuticals Prolotherapy Product Offerings
Table 68. Sanctus drugs & Pharmaceuticals Prolotherapy Revenue (US$, Mn) & (2018-2023)
Table 69. Sanctus drugs & Pharmaceuticals Key News & Latest Developments
Table 70. Hospira Pharmaceutical Company Company Summary
Table 71. Hospira Pharmaceutical Company Prolotherapy Product Offerings
Table 72. Hospira Pharmaceutical Company Prolotherapy Revenue (US$, Mn) & (2018-2023)
Table 73. Hospira Pharmaceutical Company Key News & Latest Developments
List of Figures
Figure 1. Prolotherapy Segment by Type in 2022
Figure 2. Prolotherapy Segment by Application in 2022
Figure 3. Global Prolotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prolotherapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Prolotherapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prolotherapy Revenue in 2022
Figure 8. By Type - Global Prolotherapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global Prolotherapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global Prolotherapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Prolotherapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global Prolotherapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Prolotherapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global Prolotherapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America Prolotherapy Revenue Market Share, 2018-2032
Figure 16. US Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Prolotherapy Revenue Market Share, 2018-2032
Figure 20. Germany Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 21. France Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Prolotherapy Revenue Market Share, 2018-2032
Figure 28. China Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 32. India Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Prolotherapy Revenue Market Share, 2018-2032
Figure 34. Brazil Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Prolotherapy Revenue Market Share, 2018-2032
Figure 37. Turkey Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Prolotherapy Revenue, (US$, Mn), 2018-2032
Figure 41. Pfizer Inc. Prolotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Baxter International Prolotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. B. Braun Prolotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson Prolotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Arthex Inc. Prolotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Terumo Corporation Prolotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Aurobindo Pharma Prolotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Shandong Qidu Pharmaceuticals Prolotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Amphastar Pharmaceuticals Inc. Prolotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sanctus drugs & Pharmaceuticals Prolotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Hospira Pharmaceutical Company Prolotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
